Nasopharyngeal Obstruction as a Cause of Malocclusion A review of the literature on nasopharyngeal obstruction as etiology of malocclusion. Initial sections discuss anatomy of the nasopharynx and physiology of nasal and oral respiration. The next parts review all possible causes of nasopharyngeal obstruction and its effect on the dentofacial skeleton. Special emphasis is made on the long face syndrome. Finally, the different methods for evaluating obstruction through X rays are described, as well as all possibilities for treatment, including the interrelation of several specialties and the role of the orthodontist.
PMID: 2132279 [PubMed - indexed for MEDLINE]
Related Links
Oral respiration: facial maldevelopment and corrective dentofacial orthopedics. [Angle Orthod. 1980]
The long face syndrome and impairment of the nasopharyngeal airway. [Angle Orthod. 1990]
[Indications and limits of rhinorrheomanometry in assessing naso-sinusal and rhinopharyngeal function] [Minerva Ortognatod. 1990]
The effect of airway interference on the growth and development of the face, jaws, and dentition. [Int J Orofacial Myology. 1982]
Tongue position and open-bite: the key roles of growth and the nasopharyngeal airway. [ASDC J Dent Child. 1981]
»

Angiogenesis as a strategic target for ovarian cancer therapy.

WA Spannuth is a Fellow in the Departments of Gynecologic Oncology and Cancer Biology, AK Sood is Professor in the Departments of Gynecologic Oncology and Cancer Biology and Director of Ovarian Cancer Research, and RL Coleman is Professor and Director of Clinical Research in the Department of Gynecologic Oncology, at the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Angiogenesis is a complex and highly regulated process that is crucial for tumor growth and metastasis. Insights into the molecular mechanisms of tumor angiogenesis have led to the identification of potential angiogenic targets and the development of novel antivascular agents. Many of these agents are being evaluated in clinical trials and have shown promising antitumor activity. This Review highlights the results of the latest clinical studies of antivascular agents in ovarian cancer and discusses the challenges and opportunities for future clinical trials.
PMID: 18268546 [PubMed - as supplied by publisher]